Atlas›Domain XII · Complementary, energy & biofield›Guide 158
Guide XII-158

Livingston-Wheeler therapy

Virginia Livingston-Wheeler1969United States
A 30 · L 58 · M 1212 interventions in the Trinity explorer
Client cardCompare
[source: …] where a claim comes from[uncertain] not confirmed in a primary source[synthesis] the writer's reconstruction

Version followed: the Livingston-Wheeler Clinic programme (San Diego, California) as described by Memorial Sloan Kettering Cancer Center's About Herbs monograph (updated 2021), the 1991 New England Journal of Medicine comparison by Cassileth and colleagues, and the 1990 American Cancer Society unproven-methods review as cited by MSK. This is a historical account written so that clinicians can recognise the regime and its components; it is not a treatment for cancer or any other disease, and there is no legitimate way for a psychotherapist to deliver it.

1. What it was

In brief. Livingston-Wheeler therapy (also called Livingston therapy) was an alternative cancer regime, popular from the 1970s to the early 1990s, built on the belief that cancer is caused by a bacterium. It combined immune-stimulating injections (including a vaccine made from the patient's own body fluids), a strict vegetarian diet, coffee enemas, vitamins, antioxidants and antibiotics. Memorial Sloan Kettering states plainly that it has not been shown to treat cancer. [source: MSK About Herbs, Livingston-Wheeler Therapy]

Who developed and ran it. Virginia Livingston-Wheeler, a physician, ran the clinic that offered it. Secondary sources give her birth name as Virginia Wuerthele, birth in 1906, the clinic's founding in San Diego in 1969 with her first husband (the name changed after a later marriage), and her death on 30 June 1990. [uncertain: secondary, unverified] Earlier papers on microorganisms in scleroderma, neoplasms and other diseases appear under the name Wuerthele-Caspe from the 1940s and 1950s. [uncertain: secondary, unverified]

Stated rationale.

  • The bacterial cause. Livingston-Wheeler held that cancer is caused by a bacterium she named Progenitor cryptocides, which she said she had isolated from cancer tissue and from the blood of patients with collagen and neoplastic diseases (her 1972 and 1974 papers in the Transactions of the New York Academy of Sciences, as listed by MSK). A weakened immune system was believed to let the organism grow, so the treatment aimed to stimulate immunity. [source: MSK]
  • The hormone claim. She also proposed that human chorionic gonadotropin (hCG), said to be produced by the organism, shields both a fetus and a tumour from immune attack. [uncertain: secondary, unverified]
  • Diet and detoxification. A strict vegetarian, so-called metabolic diet and coffee enemas were presented as supporting immunity and detoxifying the body. [source: MSK] Secondary sources add avoidance of poultry, based on her belief that chickens carried the organism, and foods said to be rich in abscisic acid. [uncertain: secondary, unverified]

What independent work found. Independent researchers never confirmed a link between this organism and cancer. When cultures supplied by Livingston-Wheeler were analysed independently, the organisms were identified as common, unrelated bacteria (MSK names Staphylococcus epidermidis and faecal streptococci among them). [source: MSK] The American Cancer Society had listed the Livingston vaccine as an unproven method of cancer treatment as early as 1968 and published a further review in 1990 urging patients not to use the regime because there was no evidence of safety or efficacy. [source: MSK reference list; OTA reference list on Quackwatch]

How it was sold to patients and referrers. The regime was presented as a physician-led, immune-based and nutritional approach to cancer, with a patent and a popular book giving it an air of scientific novelty: a 1983 US patent on an immune-stimulating extraction fraction and the 1984 book The Conquest of Cancer: Vaccines and Diet (Livingston-Wheeler and Addeo, Franklin Watts) are listed among the US Office of Technology Assessment's references. [source: OTA reference list on Quackwatch] Livingston-Wheeler testified at the Office of Technology Assessment's 1990 inquiry into unconventional cancer treatments shortly before her death. [uncertain: secondary, unverified] The OTA's references also list a 1987 Social Security Administration decision titled In the Matter of Virginia C. Livingston, M.D.; its content is [uncertain: not verified].

Regulatory history. A 1990 California Department of Health Services order against the clinic's use of its vaccine is widely referred to in the literature on this regime; its date, wording and scope are [uncertain: not verified]. The clinic is reported to have continued for some years after the founder's death; the date it closed is [uncertain: not verified].

2. What was actually done

The sources give the components but not a session-by-session timetable. The sequence below is ordered as a patient would meet the components; where order or frequency is not documented, this is marked. No amounts, schedules or preparation details are given, by design.

  1. Selection and assessment. Patients were self-referred, often with advanced disease. In the Cassileth study the Livingston-Wheeler patients were people with late-stage cancer who had chosen the clinic themselves. [source: MSK; Cassileth et al. 1991 as summarised by MSK and Fugh-Berman 1999] Body fluids were cultured to look for the claimed organism; antibiotics are reported to have been chosen by testing them against each patient's own cultures. [uncertain: secondary, unverified]
  2. Consent and framing. The patient was told, in effect, that a hidden infection and a weak immune system explained their cancer and that the clinic's programme corrected both. Specific consent documents or scripts are [uncertain: not verified]. Many patients combined the programme with conventional oncology: in the Cassileth comparison some Livingston-Wheeler patients were also receiving conventional therapy. [source: Fugh-Berman 1999]
  3. The autogenous vaccine. An individual vaccine was made for each patient from their own material and given by injection. MSK describes it as made from the patient's own urine; secondary sources describe it as killed bacteria grown from the patient's body fluids. [source: MSK; uncertain: secondary, unverified for the alternative description] Patients reported malaise, aching, slight fever and tenderness where it was injected. [source: MSK]
  4. BCG and other immune stimulants. Patients received BCG (the antituberculosis vaccine) as an immune stimulant. [source: MSK; Fugh-Berman 1999] Gamma globulin is also reported among the immune enhancers. [uncertain: secondary, unverified]
  5. The diet. A strict vegetarian, whole-food, low-salt diet with emphasis on raw fruit and vegetables, avoidance of poultry and, in some accounts, of other animal foods and processed food. [source: MSK for strict vegetarian diet; uncertain: secondary, unverified for the other rules] Nutritional counselling accompanied it. [source: MSK]
  6. Coffee enemas. Patients were taught to give themselves coffee enemas, presented as detoxification, and continued them at home. [source: MSK for the component; the home setting is inferred from the nature of the practice and is uncertain]
  7. Supplements and antibiotics. Vitamins and antioxidants, and antibiotics directed at the supposed organism. [source: MSK]
  8. Group support and counselling. Support groups and counselling formed part of the package. [source: MSK] This is relevant to clinicians: the psychological support offered inside the regime was bundled with its causal story.
  9. Judging progress and handling non-response. How the clinic judged progress, and how it handled worsening disease or a patient's wish to stop, is not documented in the sources used here. [uncertain: not verified] In comparable regimes, worsening is commonly reframed as detoxification or as the patient's non-adherence; whether this happened here is [uncertain: not verified].

Named variant. The 1968 American Cancer Society listing targeted the vaccine alone (the Livingston vaccine); by the 1970s and 1980s the package had grown into the combined vaccine-diet-enema programme. [source: OTA reference list; MSK]

3. How it caused harm

Lost survival benefit and lost time. The one prospective comparison (Cassileth et al., NEJM 1991; matched, self-selected, not randomised; 78 Livingston-Wheeler patients) found no survival difference between the Livingston-Wheeler cohort and patients treated at a conventional cancer centre. [source: MSK; Fugh-Berman 1999] The study was in late-stage disease; the lead investigator cautioned against generalising to earlier disease, where effective treatment changes survival. [uncertain: secondary, unverified] More broadly, a 2018 US National Cancer Database study found that people with curable breast, colorectal, lung or prostate cancer who chose alternative medicine alone had about two and a half times the risk of death of matched patients receiving conventional treatment (five-year survival roughly 55% versus 78%), with the largest excess in breast cancer. [source: Johnson et al. 2018, JNCI] This is the main mechanism of harm for any alternative regime chosen instead of treatment.

Worse quality of life. In the Cassileth study, quality of life was consistently lower in the Livingston-Wheeler cohort than in conventionally treated patients. [source: MSK] Secondary accounts note the Livingston-Wheeler group also started with worse quality of life. [uncertain: secondary, unverified]

Nutritional harm. The strict metabolic diet carries risks of deficiency in calcium, iron, vitamins D and B12 and protein, with anaemia and malabsorption, which MSK says makes it unsuitable for some cancer patients. [source: MSK] In people already losing weight from cancer or its treatment, a restrictive diet can deepen malnutrition. [synthesis]

Coffee enemas: infection, fluid and electrolyte loss, death. Repeated coffee enemas have been linked to several deaths from serious infection and from electrolyte imbalance. MSK cites a case of fatal fluid and electrolyte imbalance, with fluid collecting around the lungs and heart, after very frequent enemas, and a 1980 JAMA report on deaths related to coffee enemas (Eisele and Reay). [source: MSK]

Injection reactions. The autogenous vaccine caused malaise, aching, fever and injection-site tenderness. [source: MSK] Reactions to BCG used outside its licensed indications are [uncertain: not verified] in the sources used here.

Antibiotic exposure. Antibiotics given against an organism that independent laboratories identified as ordinary bacteria exposed patients to side effects without benefit. [synthesis, from MSK's account of the culture findings]

Psychological harm. [synthesis] Recurring themes in clinical work with people who used regimes like this: a causal story that blames a hidden infection, the person's diet or their adherence; guilt when the disease progresses; disrupted relationships with oncologists; family conflict over the choice; and complicated grief and regret in relatives after a death. No documented psychological case reports for this regime are cited here. [uncertain: not verified]

Financial harm. The regime was paid for privately; costs and any insurance disputes are [uncertain: not verified].

Who was most at risk. People with advanced or frightening diagnoses seeking control and hope; people who distrusted mainstream medicine; and people with treatable early-stage cancers who could have been cured by standard treatment. The 2018 study found choosing alternative medicine was more common among younger, female, more highly educated and higher-income patients, and in the US Pacific and Intermountain West regions. [source: Johnson et al. 2018] People who are already underweight, frail, or have kidney or heart problems are at particular risk from enemas and restrictive diets. [synthesis]

4. Recognising it today

The Livingston-Wheeler name is now rarely used, but each of its parts circulates in current alternative-cancer marketing, books, online communities and some private clinics. [synthesis]

Features and rationales that echo it

  • A single microbial cause of all cancer. Claims that cancer is caused by a hidden, shape-shifting (pleomorphic) bacterium, fungus or parasite that only the practitioner's own test can detect, and that conventional laboratories miss. [synthesis; the original claim and its non-replication: source: MSK]
  • Personalised vaccines made from the patient's own urine, blood or cultures outside a registered clinical trial, or urine-based therapies sold as immune stimulation. [synthesis]
  • Coffee enemas presented as liver detoxification, often with juicing and a strict plant-only or raw diet; the same component appears in other named regimes in this family. [synthesis; enema harms: source: MSK]
  • Immune-boosting packages combining injections, supplements, antioxidants and a restrictive diet, priced as a programme rather than item by item. [synthesis]
  • The hCG story: that a pregnancy hormone hides tumours from the immune system and that home hCG tests detect cancer. [uncertain: secondary, unverified for the original claim; synthesis for current circulation]
  • Old books and testimonials recirculated online with the founder presented as a suppressed pioneer. [synthesis]

Phrases and red flags (from the FTC's enforcement against cancer cure marketing, plus clinical synthesis)

  • Claims to "prevent, treat, or cure" cancer, or to be "clinically proven" without published trials. [source: FTC 2008]
  • One product or programme claimed to treat many unrelated diseases (for this regime, cancer and HIV/AIDS; MSK notes no studies support either). [source: FTC 2008; MSK]
  • Claims to reduce the side effects of chemotherapy and radiation as a lead-in to replacing them. [source: FTC 2008]
  • Advice to delay or decline surgery, chemotherapy or radiotherapy; hostility to the oncologist; a request not to tell the treating team. [synthesis]
  • Worsening symptoms reframed as detoxification or healing crisis; blame placed on the patient's adherence or attitude. [synthesis]
  • Up-front payment for packages, travel to an out-of-state or overseas clinic, testimonials as the main evidence. [synthesis]

Red flags in a colleague's or service's practice [synthesis]

  • A therapist, coach or counsellor who endorses, sells or refers to a regime like this, takes commission, or frames cancer as caused by emotions, toxins or a hidden infection that the client must cleanse.
  • Support groups attached to a clinic that discourage contact with oncology or treat doubt as disloyalty.
  • Wellness or integrative services that offer enemas, injections or restrictive diets to people with cancer without the treating oncologist's knowledge.

How close legitimate practices differ [synthesis]

  • Infection-associated cancers are real (for example, specific viruses and Helicobacter pylori), and are prevented or treated through vaccination and standard medicine, not through a universal cancer germ found only by one laboratory. MSK lists the published literature on infection-associated cancer prevention alongside its monograph. [source: MSK reference list]
  • Cancer immunotherapy and cancer vaccines used in oncology are tested in registered trials, licensed for defined indications and given by oncology teams; BCG has licensed oncological uses only under specialist care. A personalised injection made in a private clinic from the patient's own urine is not this. [synthesis]
  • Integrative oncology (see entry 172) offers complementary approaches alongside, never instead of, standard treatment, coordinated with the oncology team, with no claim to cure. [synthesis]
  • Oncology dietetics addresses weight loss and nutrition under a dietitian, and does not impose restrictive diets as tumour treatment. [synthesis]
  • Psycho-oncology and support groups run within or alongside cancer services support the person without a causal story about the disease and without selling treatment. [synthesis]

5. What to do instead and how to help those harmed

Current recommended alternatives. For the cancer itself: evidence-based oncology care (surgery, radiotherapy, systemic treatment, licensed immunotherapy and registered clinical trials) decided with the treating team. For symptoms, distress and quality of life: palliative and supportive care from diagnosis onward, psycho-oncology, oncology dietetics, and integrative oncology delivered alongside standard care (entry 172). Patients considering any product should discuss it with their treatment team first, as the FTC advises. [source: FTC 2008 for the last point; synthesis for the rest]

Stance. [synthesis] The psychotherapist does not perform, sell, recommend or argue the medical merits of any cancer treatment and never advises starting, stopping or changing a treatment or medicine; those decisions belong to the client with their doctors. The therapist's job is to help the client think clearly, feel less alone, stay connected to medical care, and be safe. Most clients who are drawn to regimes like this want control, hope, a coherent explanation and to be taken seriously; meet those needs directly.

All guidance in this section is the author's synthesis from general psycho-oncology and ethics practice unless a source is named. [synthesis]

5.1 Asking about alternative and complementary use

  • Purpose: find out early, without shame, what the client is using or considering, so risk and coordination can be addressed. Use at intake for anyone with cancer and whenever treatment decisions are near.
  • Steps: (1) Ask routinely, as you would about sleep or alcohol. (2) Ask what, from whom, since when, at what cost, and whether the oncology team knows. (3) Ask about enemas, injections, restrictive diets and supplements specifically, because clients may not count them as treatment. (4) Record it factually in the notes. (5) Thank them for telling you.
  • Example language (illustrative): "Lots of people with cancer try things outside the hospital. What are you using or thinking about, alongside or instead of your treatment?" / "Does your oncologist know about the injections and the enemas? I ask because some of these can interact with treatment or cause dehydration."
  • Watch for: hesitation or secrecy (fear of being judged); a clinic or group that has told them not to tell doctors; plans to stop or delay standard treatment. It is working when the client brings updates unprompted.

5.2 Exploring meaning, hopes and the explanatory model

  • Purpose: understand what the regime means to the client (control, hope, purity, distrust of medicine, identity, a community, a loved one's wishes) before any decision talk.
  • Steps: (1) Ask how they understand what caused their cancer and what they believe will help. (2) Ask what drew them to this approach and what it gives them that standard care does not. (3) Reflect the underlying need (control, being heard, fewer side effects, fear of dying). (4) Ask about past experiences with medicine that shape trust. (5) Note where the causal story produces self-blame.
  • Example language (illustrative): "What makes sense to you about the infection explanation? What does it give you?" / "It sounds like having something you can do every day matters a lot after feeling so powerless in hospital."
  • Watch for: guilt ("I caused this by what I ate"); magical thinking under extreme fear; signs of a high-control group. Working when the client can name their needs separately from the regime.

5.3 Autonomy-respecting decision support

  • Purpose: help a competent adult make an informed, values-based choice without coercion, including choices the therapist disagrees with.
  • Steps: (1) Clarify the decision actually in front of them (add something alongside, delay, or replace treatment). (2) Help them list what they know and what they still need to ask their oncologist: expected benefit of standard treatment at their stage, what delay would mean, what side effects can be managed. (3) Help them prepare questions to bring to the clinic offering the regime too (published evidence, cost, what happens if the disease progresses). (4) Explore values: time, function, being at home, family. (5) Encourage a second oncology opinion if trust has broken down. (6) Respect the decision; keep the door open. Use published decision aids only where you have reviewed them. [synthesis]
  • Example language (illustrative): "This is your decision. My part is to make sure you have what you need to make it. What would you want your oncologist to answer before you decide?" / "Some people worry that saying yes to treatment means giving up control. Is that part of this for you?"
  • Watch for: pressure from family, a seller or a group; decisions made in panic; the therapist's own urgency turning into argument (which tends to harden positions). Working when the client gets answers from the medical team and can explain their choice in their own terms.

5.4 Coordination with the oncology, primary care and palliative teams

  • Purpose: keep the client's care joined up and safe, with consent.
  • Steps: (1) Ask for written consent to talk with the oncologist, GP or primary care doctor, and palliative team. (2) Share only what is relevant: that the client is using or considering an alternative regime, and any safety concerns (enemas, restrictive diet, weight loss, injections). (3) Ask the team how they would like concerns flagged. (4) Suggest an early referral to palliative or supportive care for symptoms and quality of life, which is compatible with active treatment. (5) Suggest dietitian involvement if the diet is restrictive.
  • Example language (illustrative): "Would it be all right if I let your oncology nurse know about the diet, so they can check your weight and bloods?" / "Palliative care isn't only for the end. They're experts in feeling better during treatment. Would you be open to meeting them?"
  • Watch for: refusal of any contact (respect it, but document the risk discussion); medical warning signs needing same-day medical review: severe diarrhoea, vomiting, dizziness or fainting, palpitations, confusion, fever, abdominal pain or rapid weight loss. [synthesis; enema and diet risks: source: MSK]

5.5 Responding to physical, eating and dependence risks

  • Purpose: respond when the regime itself is a danger.
  • Steps: (1) Ask about weight change, appetite and how rigidly the diet is followed. (2) Screen for restrictive or orthorexic patterns and for prior eating disorders, which can be reactivated by purity diets. (3) Ask how often enemas are being used without asking for quantities, and whether there has been dizziness, cramps or weakness. (4) Route all medical questions to the treating doctors; urge urgent care for warning signs. (5) Assess whether the client has capacity for the decision when they are very ill, confused or malnourished, and involve the medical team if not.
  • Example language (illustrative): "Has your weight changed since you started the diet? Have you felt faint or shaky?" / "I'm not able to advise on the enemas, but those symptoms need a doctor today."
  • Watch for: rapid weight loss, fear of eating outside the rules, compulsive cleansing, distress when rules are broken. Working when the client accepts medical and dietetic review.

5.6 Grief, regret and guilt after choosing an alternative

  • Purpose: help clients and bereaved relatives who now believe the alternative cost time, money or life.
  • Steps: (1) Let the story be told in full without correcting it. (2) Separate hindsight knowledge from what was known and felt at the time (fear, hope, the clinic's assurances, a physician's authority). (3) Address self-blame and blame of others with compassion-focused and cognitive work; consider complicated or prolonged grief and its established treatments if criteria are met. (4) Acknowledge betrayal or moral injury when the person feels misled by a doctor. (5) For people still living with cancer, help them re-engage with oncology without shame.
  • Example language (illustrative): "You chose with the information and the fear you had then. Hindsight gives you facts you didn't have." / "It makes sense to feel angry at the people who sold you that certainty."
  • Watch for: suicidal thinking in bereaved relatives or in patients facing progression (assess using standard risk assessment); shame preventing return to the oncologist. Working when guilt softens into grief and the person can talk about the loss itself.

5.7 Family conflict

  • Purpose: help families where members disagree sharply about alternative treatment.
  • Steps: (1) Meet with consent; establish that the patient's decision is theirs. (2) Help each member say what they fear rather than argue evidence. (3) Agree on shared aims (comfort, honesty, staying connected, keeping the doctor informed). (4) Help relatives find ways to disagree without withdrawing support. (5) Offer separate support to relatives who feel unable to stop a choice they believe is harmful.
  • Example language (illustrative): "Underneath the argument about the diet, I hear two people who are both terrified of losing each other." / "Can we agree that whatever she decides, she won't be facing it alone?"
  • Watch for: coercion in either direction; children caught between parents' positions; relatives later blamed for not having stopped it. Working when the family can stay in contact through the illness.

5.8 Financial harm

  • Purpose: address debt, savings loss and exploitation.
  • Steps: (1) Ask about costs, payment plans, fundraising or crowdfunding, and borrowing. (2) Normalise shame about money spent. (3) Signpost to financial advice, hospital social work, and consumer complaints where marketing was deceptive. (4) Watch for repeat targeting (follow-up packages, new products). [synthesis]
  • Example language (illustrative): "Can we look at what this has cost, so you're not carrying that alone?"
  • Watch for: concealment from family; pressure to buy more after deterioration. Working when the client has a plan and support.

5.9 Safeguarding

  • Purpose: protect children and adults at risk.
  • Steps: (1) If a child with cancer is being kept from effective medical treatment or given harmful procedures, this is a safeguarding concern: consult your safeguarding lead and follow local child-protection procedures; do not delay over parental objection. (2) Children have a right to have their views heard and to give assent appropriate to their age; capacity and consent for children follow local law. (3) For adults who may lack capacity, are being pressured or financially exploited, use adult safeguarding procedures. (4) Document the concern, advice sought and actions. Never name the child outside the safeguarding route. [synthesis]
  • Example language (illustrative): "I'm worried about whether your child is getting the treatment the doctors recommend, and in that situation I have to talk to colleagues whose job is to keep children safe. I'd like to do that with you, not behind your back."
  • Watch for: missed oncology appointments for a child; restrictive diets in a child with weight loss; enemas or injections given to a child. Working when the child's medical team is involved.

5.10 Reporting

  • Purpose: use the right route when marketing is deceptive or a practitioner endangers patients.
  • Steps: (1) Deceptive cancer-cure marketing in the US: the Federal Trade Commission (reportfraud.ftc.gov). [source: FTC 2008] (2) Unapproved products or injuries from products: the national medicines and devices regulator (in the US the FDA; elsewhere the national equivalent). [uncertain: not verified for specific reporting routes] (3) A licensed doctor or other health professional providing such treatment: their licensing board. [synthesis] (4) Advertising: the national advertising regulator. [synthesis] (5) Discuss with the client first; report with consent unless there is a safeguarding or legal duty to act without it. (6) Take supervision and keep a record.
  • Example language (illustrative): "Would you like help making a complaint about how this was advertised to you? It may protect other people."
  • Watch for: the client's fear of retaliation or of being shamed; your own over-involvement. Working when the client feels the choice to report was theirs.

5.11 The therapist's own ethics

  • Steps: Do not sell, recommend or receive commission on any treatment or product; declare and manage conflicts of interest; stay within competence on medical matters and refer; avoid exploiting a client's hope; seek supervision when your own views on alternative medicine run strong. The relevant duties appear in the profession's ethics code (for psychologists, the APA Ethical Principles); the specific standards are [uncertain: not verified] here. [synthesis]
  • Example language (illustrative): "I don't recommend or advise against medical treatments. That's for you and your doctors. I'm here to help you think it through."
  • Watch for: drifting into debate about the evidence; colluding to keep the regime from the medical team.

Problems not covered by the sources [synthesis]

  • Client asks the therapist to endorse the regime: decline warmly, restate your role, explore what endorsement would mean to them.
  • Client stops attending after you raise concerns: send a brief, non-judgemental message that the door is open.
  • Health anxiety after recovery: cancer survivors may develop fear of recurrence; use established psychological approaches (see Domain II).
  • Rupture over a referral to safeguarding: name it, repair, keep the focus on safety.

Sources

← Previous · XII-157Issels' whole-body therapyNext · XII-159 →Caesium chloride high-pH therapy